Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Hepatocellular 6Drug-Related Side Effects and Adverse Reactions 2Colorectal Neoplasms 2Advanced Gastric Cancer 2Uterine Cervical Neoplasms 1Stomach Neoplasms 1Solid Tumor 1Small Cell Lung Carcinoma 1Quality of Life 1Peritoneal Metastases From Gastric Cancer 1Ovarian Cancer Recurrent 1Osteosarcoma 1Meningioma 1Immune Checkpoint Inhibition 1Gastrointestinal Stromal Tumors 1Esophageal Neoplasms 1Chondrosarcoma 1Cholangiocarcinoma 1Carcinoma, Non-Small-Cell Lung 1Advanced Gastric Adenocarcinoma 1

Interventions

apatinib 1Yoga 1Referral and Consultation 1Palliative Care 1Gardening 1Exercise 1Educational Status 1Diet Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Quality of Life × apatinib × Clear all
NCT02998242 2019-05-21

ARCAP

Sichuan Provincial People's Hospital

Phase NA Completed
40 enrolled

Quality of Life

Data powered by HemOnc (CC BY 4.0) Colophon âš¡